Respiratory system

Published on 06/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3387 times

TOPIC 2 Respiratory system

Imaging – Plain radiography

Test: The chest x-ray

Interstitial disease

The interstitial space surrounds bronchi, vessels and groups of alveoli. Disease in the interstitium manifests itself by reticulonodular shadowing (criss cross lines or tiny nodules or both). The main two processes affecting the interstitium are accumulation of fluid (pulmonary oedema) and inflammation leading to fibrosis (Fig. 2.2 and Box 2.1).

Pulmonary oedema may be cardiogenic or noncardiogenic. In congestive heart failure, the pulmonary capillary wedge pressure (PCWP) rises and the upper zone veins dilate – this is called upper zone blood diversion. With increasing PCWP, interstitial oedema occurs with the appearance of Kerley B lines and prominence of the interlobar fissures. Increased PCWP above this level causes alveolar oedema, often in a classic perihilar ‘bat wing’ pattern. Pleural effusions also occur. Unusual patterns may be found in patients with chronic obstructive pulmonary disease (COPD) who have predominant upper lobe emphysema.

A helpful mnemonic for noncardiogenic pulmonary oedema is NOT CARDIAC: near-drowning, oxygen therapy, transfusion or trauma, CNS disorder, ARDS, aspiration, or altitude sickness, renal disorder, drugs, inhaled toxins, allergic alveolitis, contrast or contusion.

COPD is often seen on CXR as diffuse hyperinflation with flattening of diaphragms and enlargement of pulmonary arteries and right ventricle (cor pulmonale). In smokers the upper lung zones are commonly diseased.

Pleural abnormalities

Other imaging

Test: Computed tomography (CT) scan (Fig. 2.4)

Test: Ventilation-perfusion scan (VQ scan) (Fig. 2.5)

Pulmonary function tests

Test: Functional residual capacity (FRC; Fig. 2.6)

Test: Volume/time curve (Fig. 2.7)

Test: Flow/volume curve (dynamic)

Interpretation

Data presented as graphs and numerical data (absolute numbers, % predicted).

Abnormalities

Test: Transfer factor/diffusing capacity

Intraoperative respiratory monitoring

Test: Pulse oximetry (SpO2)

Test: Capnography

Physiological principles

During the respiratory cycle exhaled CO2 produces a display of instantaneous CO2 concentration versus time. In the healthy patient, end-tidal CO2 (PETCO2) closely approximates to arterial CO2 (PaCO2). CO2 in exhaled gas is dependent on its carriage from site of production in the tissues to the lungs via the right heart (Table 2.1). Thus capnography also provides limited but useful information on cardiac output, pulmonary blood flow and the diffusion of pulmonary capillary gases. A mismatch between PETCO2 and PaCO2 may occur due to both physiological and pathological processes.

Table 2.1 Conditions affecting arterial – end-tidal CO2 gradient

Increasing gradient Decreasing gradient
Age Increased cardiac output
COPD Low frequency ventilation
Pulmonary embolism Pregnancy
Reduced cardiac output Infants under anaesthesia
Hypovolaemia  
General anaesthesia  

Test: Shunt fraction

Pressure–volume (P/V) curve analysis

Test: Static airway compliance

Blood gas analysis

Test: Arterial blood gas analysis

Interpretation

See Table 2.3.

Table 2.3 Definitions and normal ranges of measured and calculated acid-base parameters breathing room air at sea level

Abbreviation Meaning Normal value
pH A measurement of the hydrogen ion concentration (log scale) 7.35–7.45
pH = pK + log ([HCO3 ]/[CO2])
PCO2 Partial pressure of CO2 4.8–5.9 kPa
PO2 Partial pressure of O2; the FiO2 must be known 11.9–13.2 kPa
BEx Base excess, a measure of the metabolic component of acid-base disorders: the calculated amount in milliequivalents of strong acid required to restore 1 litre of fully saturated blood to pH 7.4, at a PCO2 of 5.3 kPa −2 to +2
More than +2 = a metabolic alkalosis; less than −2 = a metabolic acidosis
sBEx Standard base excess: the calculated base excess after the sample has been equilibrated (‘standardized’) with CO2 at 5.3 kPa at 37°C, saturated with oxygen and a haemoglobin of 5 g/dL −2 to +2
BDef Base deficit: a measure of the metabolic component of acid-base disorders; is the opposite of base excess −2 to +2
Total CO2 = CO2 + HCO3 22–32 mEq/L
sHCO3 Standard bicarbonate: the calculated bicarbonate concentration after the sample has been equilibrated (‘standardized’) with CO2 at 5.3 kPa at 37°C and saturated with oxygen. Like base excess, a measure of the purely metabolic component 22–26 mmol/L
aHCO3 Actual bicarbonate: the bicarbonate calculated from the measured CO2 and pH; values vary if the CO2 is abnormal 22–26 mmol/L